Aktis Oncology Raises $84 Million to…
CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Read More
Investor Login
Toggle navigation
Home
About
About Us
News & Events
For Entrepreneurs
Contact Us
Team
Portfolio
Ventures
Specialized Fund Management
About
Chiesi Ventures Fund
Asia Innovation Ventures
AgTech Initiatives
Specialized Holdings
Translational Medicine
About
Wake Forest Technology Development Program
Home
About
Team
Portfolio
News & Events
Contact
Ventures
Specialized Funds
Translational Medicine
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.
Investor Login
Investor Login
© 2018 Pappas Capital, LLC. ALL RIGHTS RESERVED.
